Dietary supplement GMP development should be higher CFSAN priority, CRN says.
This article was originally published in The Tan Sheet
Executive Summary
SUPPLEMENT GMP DEVELOPMENT HIGHER PRIORITY AT CFSAN URGED BY CRN Director of Scientific and Regulatory Affairs Annette Dickinson, PhD, at a Center for Food Safety & Applied Nutrition meeting in Washington, D.C. June 25. CFSAN called the public meeting to discuss its agenda and set priorities in light of Section 406 of the FDA Modernization Act that requires FDA to publish a plan for complying with its statutory obligations on the one-year anniversary of enactment of the law.